The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century

Saverio Caini(Netherlands Institute for Health Services Research), Gabriela Kusznierz(National Institute of Cardiovascular Diseases), Verónica Vera Garate(National Institute of Cardiovascular Diseases), Sonam Wangchuk(Royal Centre for Disease Control), Binay Thapa(Royal Centre for Disease Control), Francisco José de Paula Júnior(Ministério da Saúde), Walquíria Aparecida Ferreira de Almeida(Ministério da Saúde), Richard Njouom(Centre Pasteur du Cameroun), Rodrigo Fasce(Instituto de Salud Pública de Chile), Patricia Bustos(Instituto de Salud Pública de Chile), Shuo Feng(Chinese Center For Disease Control and Prevention), Zhibin Peng(Chinese Center For Disease Control and Prevention), Jenny Lara Araya, Alfredo Bruno(Instituto Nacional de Investigación en Salud Pública), Doménica de Mora(Instituto Nacional de Investigación en Salud Pública), Mónica Jeannette Barahona de Gámez(Ministerio de Salud), Richard Pebody(Public Health England), Maria Zambon(Public Health England), Rocio Higueros(Ministry of Public Health and Social Assistance), Rudevelinda Rivera, Herman Kosasih, Maria Rita Castrucci, Antonino Bella, Hervé Kadjo(Institut Pasteur de Côte d'Ivoire), Daouda Coulibaly(Institut National d’Hygiène Publique), Ainash Makusheva(National Center of Public Health of the Ministry of Health of the Republic of Kazakhstan), Ольга Эрнестовна Бессонова(National Center of Public Health of the Ministry of Health of the Republic of Kazakhstan), Sandra S. Chaves(Centers for Disease Control and Prevention), Gideon O. Emukule(Centers for Disease Control and Prevention), Jean‐Michel Héraud(Institut Pasteur de Madagascar), Norosoa Harline Razanajatovo(Institut Pasteur de Madagascar), Amal Barakat(Institut National d'Hygiène du Maroc), Fatima El Falaki(Institut National d'Hygiène du Maroc), Adam Meijer(National Institute for Public Health and the Environment), Gé Donker(Netherlands Institute for Health Services Research), Q. Sue Huang(New Zealand Institute for Public Health and Forensic Science), Tim Wood(New Zealand Institute for Public Health and Forensic Science), Ángel Balmaseda, Rakhee Palekar(World Health Organization Regional Office for the Americas), Brechla Moreno Arévalo, Ana Paula Rodrigues(National Institute of Health Dr. Ricardo Jorge), Raquel Guiomar(National Institute of Health Dr. Ricardo Jorge), Vernon Jian Ming Lee(Ministry of Health), Li Wei Ang(Ministry of Health), Cheryl Cohen(National Health Laboratory Service), Florette K. Treurnicht(National Health Laboratory Service), Alla Mironenko(L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine), Olha Holubka(L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine), Joseph Bresee(Centers for Disease Control and Prevention), Lynnette Brammer(Centers for Disease Control and Prevention), Mai thi Quynh Le(National Institute Of Hygiene And Epidemiology), Phuong Vu Mai Hoang(National Institute Of Hygiene And Epidemiology), Clotilde El Guerche‐Séblain(Sanofi (France)), John Paget(Netherlands Institute for Health Services Research), the Global Influenza B Study team
PLoS ONE
September 12, 2019
Cited by 182Open Access
Full Text

Abstract

We describe the epidemiological characteristics, pattern of circulation, and geographical distribution of influenza B viruses and its lineages using data from the Global Influenza B Study. We included over 1.8 million influenza cases occurred in thirty-one countries during 2000-2018. We calculated the proportion of cases caused by influenza B and its lineages; determined the timing of influenza A and B epidemics; compared the age distribution of B/Victoria and B/Yamagata cases; and evaluated the frequency of lineage-level mismatch for the trivalent vaccine. The median proportion of influenza cases caused by influenza B virus was 23.4%, with a tendency (borderline statistical significance, p = 0.060) to be higher in tropical vs. temperate countries. Influenza B was the dominant virus type in about one every seven seasons. In temperate countries, influenza B epidemics occurred on average three weeks later than influenza A epidemics; no consistent pattern emerged in the tropics. The two B lineages caused a comparable proportion of influenza B cases globally, however the B/Yamagata was more frequent in temperate countries, and the B/Victoria in the tropics (p = 0.048). B/Yamagata patients were significantly older than B/Victoria patients in almost all countries. A lineage-level vaccine mismatch was observed in over 40% of seasons in temperate countries and in 30% of seasons in the tropics. The type B virus caused a substantial proportion of influenza infections globally in the 21st century, and its two virus lineages differed in terms of age and geographical distribution of patients. These findings will help inform health policy decisions aiming to reduce disease burden associated with seasonal influenza.


Related Papers

No related papers found

Powered by citation graph analysis